首页> 美国卫生研究院文献>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease >Endothelial Cell‐ Platelet‐ and Monocyte/Macrophage‐Derived Microparticles are Elevated in Psoriasis Beyond Cardiometabolic Risk Factors
【2h】

Endothelial Cell‐ Platelet‐ and Monocyte/Macrophage‐Derived Microparticles are Elevated in Psoriasis Beyond Cardiometabolic Risk Factors

机译:牛皮癣中的内皮细胞血小板和单核细胞/巨噬细胞衍生的微粒升高超过了心脏代谢风险因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPsoriasis, especially when severe, is a risk factor for cardiometabolic disease beyond traditional risk factors. The mechanism of atherogenesis in psoriasis remains unknown. Cell membrane vesicles (ie, microparticles), released upon cell activation or apoptosis, have recently been associated with cardiometabolic disease and may play a pathogenic role. Microparticle levels, particularly from endothelial cells and platelets, are elevated in patients with cardiovascular disorders, metabolic syndrome, other inflammatory diseases, autoimmune conditions, and have been shown to be predictive of cardiovascular outcomes.
机译:背景技术银屑病,尤其是严重的牛皮癣,是心脏代谢疾病的一个传统危险因素以外的危险因素。银屑病中动脉粥样硬化的机制仍然未知。细胞活化或凋亡后释放的细胞膜囊泡(即微粒)最近与心脏代谢疾病有关,可能起着致病作用。在患有心血管疾病,代谢综合症,其他炎症性疾病,自身免疫性疾病的患者中,尤其是来自内皮细胞和血小板的微粒水平升高,并且已被证明可预测心血管疾病的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号